These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 22496474

  • 21. Safe use of hemodialysis for dabigatran removal before cardiac surgery.
    Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G.
    Ann Pharmacother; 2012 Sep; 46(9):e21. PubMed ID: 22872748
    [Abstract] [Full Text] [Related]

  • 22. Acute pulmonary emboli in a patient on long-term dabigatran therapy.
    Rafferty JA, Prom R, Kujawski SZ.
    Ann Pharmacother; 2013 Apr; 47(4):e20. PubMed ID: 23535815
    [Abstract] [Full Text] [Related]

  • 23. Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
    Hohnloser SH, Oldgren J, Yang S, Wallentin L, Ezekowitz M, Reilly P, Eikelboom J, Brueckmann M, Yusuf S, Connolly SJ.
    Circulation; 2012 Feb 07; 125(5):669-76. PubMed ID: 22215856
    [Abstract] [Full Text] [Related]

  • 24. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D, Taylor M.
    Ann Pharmacother; 2012 Jan 07; 46(1):e3. PubMed ID: 22202498
    [Abstract] [Full Text] [Related]

  • 25. Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification.
    Clemens A, Haertter S, Friedman J, Brueckmann M, Stangier J, van Ryn J, Lehr T.
    Curr Med Res Opin; 2012 Feb 07; 28(2):195-201. PubMed ID: 22208675
    [Abstract] [Full Text] [Related]

  • 26. Hemopericardium in a patient treated with dabigatran etexilate.
    Barton CA, McMillian WD, Raza SS, Keller RE.
    Pharmacotherapy; 2012 May 07; 32(5):e103-7. PubMed ID: 22488474
    [Abstract] [Full Text] [Related]

  • 27. Impaired renal function and bleeding in elderly treated with dabigatran.
    Berthelot E, Lavenu-Bombled C, Orostegui-Giron L, Desconclois C, Assayag P.
    Blood Coagul Fibrinolysis; 2014 Sep 07; 25(6):618-20. PubMed ID: 24509332
    [Abstract] [Full Text] [Related]

  • 28. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM.
    Clin Toxicol (Phila); 2015 Mar 07; 53(3):156-63. PubMed ID: 25661675
    [Abstract] [Full Text] [Related]

  • 29. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C, George J, Levine R.
    N Z Med J; 2013 Mar 01; 126(1370):110-2. PubMed ID: 23474519
    [Abstract] [Full Text] [Related]

  • 30. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
    Augoustides JG.
    J Cardiothorac Vasc Anesth; 2011 Dec 01; 25(6):1208-12. PubMed ID: 21982327
    [Abstract] [Full Text] [Related]

  • 31. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD, Bona R, Baker WL.
    Adv Ther; 2011 Jun 01; 28(6):460-72. PubMed ID: 21533567
    [Abstract] [Full Text] [Related]

  • 32. Hemorrhagic complications associated with dabigatran use.
    Chen BC, Viny AD, Garlich FM, Basciano P, Howland MA, Smith SW, Hoffman RS, Nelson LS.
    Clin Toxicol (Phila); 2012 Nov 01; 50(9):854-7. PubMed ID: 22970730
    [Abstract] [Full Text] [Related]

  • 33. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug 01; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 34. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J, Pike G, Keighley-Jones L, Nash MJ.
    Am J Med; 2013 Aug 01; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract] [Full Text] [Related]

  • 35. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
    Garwood CL, Hwang JM, Moser LR.
    Pharmacotherapy; 2011 Dec 01; 31(12):1208-20. PubMed ID: 22122182
    [Abstract] [Full Text] [Related]

  • 36. Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Finsterer J, Stöllberger C, Paul G, Bastovansky A.
    Cardiovasc Ther; 2013 Dec 01; 31(6):e111-4. PubMed ID: 24279385
    [Abstract] [Full Text] [Related]

  • 37. Evaluating and assessing dabigatran drug interactions.
    Nguyen T, Wong E.
    Consult Pharm; 2012 Jul 01; 27(7):509-12. PubMed ID: 22910132
    [Abstract] [Full Text] [Related]

  • 38. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J, Taskiran M.
    Ugeskr Laeger; 2013 Feb 04; 175(6):334-6. PubMed ID: 23402236
    [Abstract] [Full Text] [Related]

  • 39. Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?
    Hughes PJ, Freeman MK.
    Consult Pharm; 2012 Jun 04; 27(6):445-52. PubMed ID: 22698551
    [Abstract] [Full Text] [Related]

  • 40. Intravenous thrombolysis in a stroke patient taking dabigatran.
    Lee VH, Conners JJ, Prabhakaran S.
    J Stroke Cerebrovasc Dis; 2012 Nov 04; 21(8):916.e11-2. PubMed ID: 22608344
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.